GLOW focuses more on collagen and remodeling pathways, while KLOW adds an additional research dimension with KPV for inflammation-response signaling
The NHS website offers helpful resources on improving sleep
Conditions such as heart disease, chronic kidney disease, and obstructive sleep apnea may affect which GLP-1 medication is chosen for treatment
Nestls Vital Pursuit launch and subsequent protein-technology work for GLP-1 users and weight management show that large food companies now see this as a distinct product platform rather than a short-term marketing theme
When asked why, she said, "I don't want to lose any more weight, so I just stopped." However, in a 2026 "Mirror, Mirror" sit-down with Amy Chang, Tutor mentioned that she still microdosed GLP-1s to maintain her weight